Literature DB >> 2010759

Could Wallerian degeneration contribute to "leuko-araiosis" in subjects free of any vascular disorder?

D Leys1, J P Pruvo, M Parent, P Vermersch, G Soetaert, M Steinling, A Delacourte, A Défossez, A Rapoport, J Clarisse.   

Abstract

To determine the possible role of Wallerian degeneration secondary to the grey matter neuronal loss in the pathogenesis of "leuko-araiosis", computerised tomography (CT) of the brain was studied in 98 normotensive and non diabetic subjects free of cardiac diseases: 32 with Alzheimer's disease, 36 with Parkinson's disease, eight with progressive supranuclear palsy, and 22 controls. In Alzheimer's disease, leuko-araiosis scores were greater than in control subjects. Leuko-araiosis was more prominent in anterior periventricular areas in Parkinson's disease and progressive supranuclear palsy, and in posterior periventricular areas in Alzheimer's disease. In two patients with Alzheimer's disease and leuko-araiosis, necropsy revealed diffuse white matter pallor, mild fibrillary astrocytosis, and in one patient limited hyaline thickening of small white matter vessels, without any infarction or hypertensive change. Changes were more severe in white matter close to cortical areas with a great density of neurofibrillary tangles. Leuko-araiosis was more severe or more widespread in Alzheimer's disease than in Parkinson's disease, progressive supranuclear palsy and normal ageing. Differences in the location of leuko-araiosis between the four groups might be due to differences in the location of the grey matter disorder and Wallerian degeneration rather than amyloid in Alzheimer's disease, Parkinson's disease, progressive supranuclear palsy and normal ageing. Wallerian degeneration might be another cause of leuko-araiosis in neuro-degenerative disorders beside previously reported extra-cerebral predisposing factors and amyloid angiopathy.

Entities:  

Mesh:

Year:  1991        PMID: 2010759      PMCID: PMC1014298          DOI: 10.1136/jnnp.54.1.46

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  23 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  Neuropathologic correlates of leuko-araiosis.

Authors:  I Janota; T R Mirsen; V C Hachinski; D H Lee; H Merskey
Journal:  Arch Neurol       Date:  1989-10

3.  Subcortical arteriosclerotic encephalopathy: a clinical and radiological investigation.

Authors:  L A Loizou; B E Kendall; J Marshall
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-04       Impact factor: 10.154

4.  Binswanger's disease: progressive subcortical encephalopathy or multi-infarct dementia?

Authors:  K Huang; L Wu; Y Luo
Journal:  Can J Neurol Sci       Date:  1985-05       Impact factor: 2.104

5.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors:  G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

6.  Pathogenesis of Binswanger chronic progressive subcortical encephalopathy.

Authors:  J De Reuck; L Crevits; W De Coster; G Sieben; H vander Eecken
Journal:  Neurology       Date:  1980-09       Impact factor: 9.910

7.  [Frontal syndrome of progressive supranuclear palsy].

Authors:  J Cambier; M Masson; F Viader; J Limodin; A Strube
Journal:  Rev Neurol (Paris)       Date:  1985       Impact factor: 2.607

8.  Subcortical dementia. Frontal cortex hypometabolism detected by positron tomography in patients with progressive supranuclear palsy.

Authors:  R D'Antona; J C Baron; Y Samson; M Serdaru; F Viader; Y Agid; J Cambier
Journal:  Brain       Date:  1985-09       Impact factor: 13.501

9.  Diagnostic evaluation of degenerative and vascular dementia.

Authors:  C Loeb; C Gandolfo
Journal:  Stroke       Date:  1983 May-Jun       Impact factor: 7.914

10.  Subcortical arteriosclerotic encephalopathy (Binswanger's disease). Computed tomographic, nuclear magnetic resonance, and clinical correlations.

Authors:  W R Kinkel; L Jacobs; I Polachini; V Bates; R R Heffner
Journal:  Arch Neurol       Date:  1985-10
View more
  33 in total

1.  White matter magnetic resonance imaging hyperintensity in Alzheimer's disease: correlations with corpus callosum atrophy.

Authors:  P Vermersch; J Roche; M Hamon; C Daems-Monpeurt; J P Pruvo; P Dewailly; H Petit
Journal:  J Neurol       Date:  1996-03       Impact factor: 4.849

2.  Clinical correlates of high signal lesions on magnetic resonance imaging in Alzheimer's disease.

Authors:  D A Bennett; D W Gilley; R S Wilson; M S Huckman; J H Fox
Journal:  J Neurol       Date:  1992-04       Impact factor: 4.849

3.  Functional and magnetic resonance imaging correlates of corpus callosum in normal pressure hydrocephalus before and after shunting.

Authors:  Maria Mataró; Mar Matarín; Maria Antonia Poca; Roser Pueyo; Juan Sahuquillo; Maite Barrios; Carme Junqué
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-10-20       Impact factor: 10.154

4.  Leukoaraiosis severity and list-learning in dementia.

Authors:  Catherine C Price; Kelly Davis Garrett; Angela L Jefferson; Stephanie Cosentino; Jared J Tanner; Dana L Penney; Rodney Swenson; Tania Giovannetti; Brianne Magouirk Bettcher; David J Libon
Journal:  Clin Neuropsychol       Date:  2009-08       Impact factor: 3.535

Review 5.  Cerebral white matter: neuroanatomy, clinical neurology, and neurobehavioral correlates.

Authors:  Jeremy D Schmahmann; Eric E Smith; Florian S Eichler; Christopher M Filley
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

Review 6.  Contemplating Alzheimer's disease and the contribution of white matter hyperintensities.

Authors:  Adam M Brickman
Journal:  Curr Neurol Neurosci Rep       Date:  2013-12       Impact factor: 5.081

7.  Leucoaraiosis, nigrostriatal denervation and motor symptoms in Parkinson's disease.

Authors:  Nicolaas I Bohnen; Martijn L T M Müller; Natalia Zarzhevsky; Robert A Koeppe; Christopher W Bogan; Michael R Kilbourn; Kirk A Frey; Roger L Albin
Journal:  Brain       Date:  2011-06-08       Impact factor: 13.501

Review 8.  Vascular parkinsonism--characteristics, pathogenesis and treatment.

Authors:  Amos D Korczyn
Journal:  Nat Rev Neurol       Date:  2015-04-28       Impact factor: 42.937

9.  Microstructural white matter alterations in patients with drug induced parkinsonism.

Authors:  Yoonju Lee; Yong Ho Choi; Jae Jung Lee; Hye Sun Lee; Young H Sohn; Jong-Min Lee; Phil Hyu Lee
Journal:  Hum Brain Mapp       Date:  2017-09-12       Impact factor: 5.038

Review 10.  Novel MRI techniques in the assessment of dementia.

Authors:  Stefan J Teipel; Thomas Meindl; Lea Grinberg; Helmut Heinsen; Harald Hampel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-03       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.